MarkJosDinubileMD

PubMed

• 3 citations
  Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease.
  Sandra Parra, Mireia Saballs, Mark DiNubile, Mireia Feliu, Simona Iftimie, Laia Revuelta, Raul Pavón, Alba Àvila, Susan Levinson, Antoni Castro> ;Atherosclerosis Plus. 2023 Jun 1
• Plasma gelsolin levels are associated with diabetes, sex, race, and poverty.
  Nicole Noren Hooten, Nicolle A Mode, Edward Kowalik, Victor Omoniyi, Alan B Zonderman, Ngozi Ezike, Mark J DiNubile, Susan L Levinson, Michele K Evans> ;Journal of Translational Medicine. 2023 Mar 10
• 4 citations
  Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus.
  Stephen R Thom, Veena M Bhopale, Awadhesh K Arya, Deepa Ruhela, Abid R Bhat, Nandita Mitra, Ole Hoffstad, D Scot Malay, Ziad K Mirza, John C Lantis, Hadar A Lev-Tov, R...> ;Immunohorizons. 2023 Jan 1
• 1 citations
  Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia.
  Mark J DiNubile, Sandra Parra, Antoni Castro Salomó, Susan L Levinson> ;Open Forum Infectious Diseases. 2022 Aug 1
• Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study.
  Timo E Strandberg, Susan L Levinson, Mark J DiNubile, Satu Jyväkorpi, Mika Kivimäki> ;Aging Clinical and Experimental Research. 2022 May 1
• 5 citations
  Recombinant Human Plasma Gelsolin (rhu-pGSN) in a Patient Hospitalized with Critical COVID-19 Pneumonia
  Julie V. Catteeuw, Mark J. DiNubile> ;Clinical Infection in Practice. 2021 Aug 10
• 8 citations
  Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression.
  Veena M. Bhopale, Deepa Ruhela, Kaighley D. Brett, Nathan Z. Nugent, Noelle K. Fraser, Susan L Levinson, Mark J. DiNubile, Stephen R. Thom> ;Journal of Applied Physiology. 2021 Mar 25
• 1 citations
  Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease
  John Audley, Emily F. Gliniewicz, Kol A. Zarember, Hanna S Hong, Gal Wald, Douglas B. Kuhns, Elizabeth M. Kang, Harry L. Malech, Anthony F. Suffredini, Robert J. Novec...> ;Inflammation. 2021 Feb 1
• 219 citations
  An immune-based biomarker signature is associated with mortality in COVID-19 patients.
  Michael S. Abers, Ottavia M. Delmonte, Emily Ricotta, Jonathan Fintzi, Danielle Fink, Adriana Almeida de Jesus, Kol A. Zarember, Sara Alehashemi, Vasileios Oikonomou, ...> ;JCI Insight. 2021 Jan 11
• 9 citations
  Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia.
  Mark J. DiNubile, Susan L Levinson, Thomas P. Stossel, Matthew B. Lawrenz, Jonathan M. Warawa> ;Open Forum Infectious Diseases. 2020 Jun 19
• 5 citations
  Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.
  Abla Tannous, Susan L Levinson, James Bolognese, Steven M. Opal, Mark J. DiNubile> ;Antimicrobial Agents and Chemotherapy. 2020 Sep 21
• 6 citations
  Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza.
  Zhiping Yang, Alice Bedugnis, Susan L Levinson, Mark J. DiNubile, Thomas P. Stossel, Quan Lu, Lester Kobzik> ;F1000research. 2019 Nov 6
• 7 citations
  Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia.
  Zhiping Yang, Alice Bedugnis, Susan L Levinson, Mark J. DiNubile, Thomas P. Stossel, Quan Lu, Lester Kobzik> ;The Journal of Infectious Diseases. 2019 Sep 26
• 10 citations
  Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes
  Wesley H. Self, Richard G. Wunderink, Mark J. DiNubile, Thomas P. Stossel, Susan L Levinson, Derek J. Williams, Evan J. Anderson, Anna M. Bramley, Seema Jain, Kathryn ...> ;Clinical Infectious Diseases. 2019 Sep 13
• 15 citations
  Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.
  Fleur P Paling, Karina Olsen, Kristin Ohneberg, Martin Wolkewitz, Vance G. Fowler, Mark J. DiNubile, Hasan S. Jafri, Frangiscos Sifakis, Marc J. M. Bonten, Stéphan Jue...> ;Plos One. 2018 Mar 21
• 17 citations
  Human papillomavirus genotypes from vaginal and vulvar intraepithelial neoplasia in females 15-26 years of age.
  Suzanne M. Garland, Elmar A. Joura, Kevin A. Ault, F. Xavier Bosch, Darron R. Brown, Xavier Castellsagué, Alex Ferenczy, Daron Gale Ferris, Anna R. Giuliano, Mauricio ...> ;Obstetrics and Gynecology. 2018 Aug 1
• 648 citations
  Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
  Francisco M. Marty, Per Ljungman, Roy F. Chemaly, Johan Maertens, Sanjeet Dadwal, Rafael F. Duarte, Shariq Haider, Andrew J. Ullmann, Yuta Katayama, Janice M. Brown, K...> ;The New England Journal of Medicine. 2017 Dec 6
• 9 citations
  Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients:...
  Kathleen Squires, Linda-Gail Bekker, Christine Katlama, Yazdan Yazdanpanah, Yan Zhou, Anthony Rodgers, Mark J. DiNubile, Peter Sklar, Randi Y. Leavitt, Hedy Teppler> ;Open Forum Infectious Diseases. 2017 Jan 1
• 127 citations
  Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
  Ole Erik Iversen, Maria Jose Miranda, Angels Ulied, Terje Soerdal, Erica Lazarus, Kulkanya Chokephaibulkit, Stan L. Block, Ales Skrivanek, Abdul Ghani Nur Azurah, Siew...> ;JAMA. 2016 Dec 13
• 306 citations
  Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
  Suzanne M. Garland, Susanne K. Kjaer, Nubia Muñoz, Stan L. Block, Darron R. Brown, Mark J. DiNubile, Brianna Lindsay, Barbara J. Kuter, Gonzalo Perez, Géraldine Domini...> ;Clinical Infectious Diseases. 2016 Aug 15
• 12 citations
  Noninferior Antibiotics: When Is “Not Bad” “Good Enough”?
  Mark J. DiNubile> ;Open Forum Infectious Diseases. 2016 May 1
• 81 citations
  Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation ...
  Maria Buti, Stuart C. Gordon, Eli Zuckerman, Eric Lawitz, Jose Luis Calleja, Harald Hofer, Christopher L. Gilbert, John Palcza, Anita Y. M. Howe, Mark J. DiNubile, Mic...> ;Clinical Infectious Diseases. 2016 Jan 1
• 66 citations
  Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir.
  Rong Liu, Stephanie Curry, Patricia McMonagle, Wendy W. Yeh, Steven W. Ludmerer, Patricia Jumes, William L. Marshall, Stephanie Kong, Paul Ingravallo, Stuart Black, Ir...> ;Antimicrobial Agents and Chemotherapy. 2015 Nov 1
• 3 citations
  Prednisolone or Pentoxifylline for Alcoholic Hepatitis.
  Mark J. DiNubile> ;The New England Journal of Medicine. 2015 Jul 16
• 396 citations
  Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Random...
  Stefan Zeuzem, Reem Ghalib, K. Rajender Reddy, Paul J. Pockros, Ziv Ben Ari, Yue Zhao, Deborah D. Brown, Shuyan Wan, Mark J. DiNubile, Bach-Yen Nguyen, Michael N. Robe...> ;Annals of Internal Medicine. 2015 Jul 7
• Join now to see all